Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Celularity Releases CEO Letter to Shareholders
-
Costco Wholesale Corporation Reports May Sales Results
-
DHT Holdings, Inc. Announces VLCC Newbuilding with Hanwha Ocean for delivery in August 2028
-
Gamma Resources Announces Closing of Amended Payment Terms Negotiation for U.S. Uranium Portfolio Lease Agreement
-
Oil-Dri Increases Dividends for 23rd Consecutive Year and Authorizes Stock Repurchases
-
Lion One Metals Announces Retirement of Founder, President, and Chairman Walter Berukoff, Transitions to Chairman Emeritus
-
YY Group (NASDAQ: YYGH) Advances AI Training Data Strategy with Launch of Training Lab and Pilot Robotics Deployments in Singapore
-
Range Impact Announces $10 Million Investment from Tacora Capital
-
Sun Communities, Inc. Declares Second Quarter 2026 Distribution
-
Spa Medicca Celebrates Grand Opening of New Alexandria, Kentucky Location
-
Genius Partners with Ergonia Trading to Launch “GeniusFi” on BNB Chain, Bringing CEX-Level Pricing On-Chain
-
Petco Reports First Quarter 2026 Results
-
Veeva Announces Fiscal 2027 First Quarter Results
-
C3 AI Announces Fiscal Fourth Quarter and Full Fiscal Year 2026 Results
-
2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
-
CrowdStrike Reports First Quarter Fiscal Year 2027 Financial Results
-
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
-
Tilly's, Inc. Fiscal 2026 First Quarter Comp Sales Increase +22.9%
-
ChargePoint Reports First Quarter Fiscal Year 2027 Financial Results
-
Reed’s Receives NYSE Deficiency Notification Regarding Stockholders’ Equity
-
Finward Bancorp Announces Dividend
-
Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
-
Red White & Bloom Brands’ Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
-
Axos Financial, Inc. Named to D.A. Davidson’s 8th Annual Gold Trophy List
-
SenesTech Announces Amendment to Equity Incentive Plan Proposal
-
J.Jill, Inc. Announces Quarterly Dividend
-
Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, June 17, 2026
-
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
-
Agilysys to Participate in the Baird Global Consumer, Technology, & Services Conference
-
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
-
Peloton Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
-
XPO Provides North American LTL Operating Data for May 2026
-
MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice
-
Mannatech Announces Results of Annual Shareholders’ Meeting
-
Exyn Technologies Presents at ROTH Capital Partners’ Drone Technology in Global Development Event at the United Nations
-
3D Systems Announces Proposed Public Offering
-
Red White & Bloom Brands’ Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
-
Netskope Announces Strong Fiscal First Quarter 2027 Financial Results
-
Nasdaq Reports May 2026 Volumes
-
Generational Group Advises Velocity Industrial, LLC in its Sale to a Strategic Buyer
-
Five Below, Inc. Announces First Quarter Fiscal 2026 Financial Results
-
Canadian Securities Exchange Welcomes Listing of Atlantico Energy Metals Corp.
-
FOX NEWS CHANNEL OUTPACES ABC NOTCHING HIGHEST RATED MAY DURING MIDTERM ELECTION YEAR IN NETWORK HISTORY
-
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
-
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
-
Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally
-
ARTHUR J. GALLAGHER & CO. TO HOST REGULARLY SCHEDULED QUARTERLY INVESTOR MEETING WITH MANAGEMENT
-
Intuit Executive Mark Notarainni to Present at the Mizuho Technology Conference
-
McGrath Declares Quarterly Dividend
-
Jade Biosciences Announces Proposed Underwritten Public Offering
